Albumin 5% Cut Mortality Rates in Sudden Liver Failure With Other Organ Failure

(MedPage Today) -- Plasma exchange with albumin 5% (Albutein 5%, PE-A5%) added to standard medical treatment (SMT) improved outcomes in patients with acute-on-chronic liver failure (ACLF), according to the randomized phase III APACHE trial. Among...
Source
MedPage Today
Opens original article in a new tab


